BioCentury | Aug 21, 2018
Company News

Management tracks: HBP parts ways with Executive Director Chris Ebell

...to 2017. Gene therapy company uniQure hired Robert Gut as CMO. He was CMO at Versartis Inc....
BioCentury | May 29, 2018
Company News

Management tracks: Axovant, Revance

...Bellicum Pharmaceuticals Inc. (NASDAQ:BLCM) hired Shane Ward as general counsel. He was general counsel for Versartis Inc....
BioCentury | Apr 23, 2018
Company News

Management tracks: Probiodrug, Alder

...Biosciences Inc. (Bedford, Mass.) appointed Joshua Brumm as CFO. He was CFO and COO at Versartis Inc....
BioCentury | Oct 13, 2017
Company News

Management tracks: Verastem, OxThera

...NYSE:BMY). Endocrine and metabolic company Versartis Inc. (NASDAQ:VSAR) terminated chief development officer Colin Hislop. He was Versartis'...
BioCentury | Oct 6, 2017
Finance

Bargain shopping

...50% to leave Zai with a market cap of $1.4 billion at the quarter’s close. Versartis Inc....
...and Drug Administration (FDA), Silver Spring, Md. Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX), Laval, Quebec Versartis Inc....
...Ltd. Genocea Biosciences Inc. Gilead Sciences Inc. Intercept Pharmaceuticals Inc. Ionis Pharmaceuticals Inc. Kite Pharma Inc. Marinus Pharmaceuticals Inc. Sanofi Teva Pharmaceutical Industries Ltd. Versartis Inc. Vertex...
BioCentury | Oct 6, 2017
Finance

High as a Kite

...stocks and drug projects,” said Brüning. Annette Grimaldi of BMO Capital Markets agreed, and highlighted Versartis Inc....
...deficiency. The NBI dropped just 0.3% on the day, while the BTK nudged up 0.2%. Versartis...
...Inc. (NASDAQ:RYTM), Boston, Mass. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Versartis Inc....
BioCentury | Sep 29, 2017
Financial News

Ascendis and Catalent price follow-ons

...its TransCon Growth Hormone (ACP-001) to treat pre-pubertal growth hormone deficiency (GHD). On Sept. 22, Versartis Inc....
...Hellerup, Denmark Catalent Inc. (NYSE:CTLT), Somerset, N.J. Elizabeth S. Eaton Somavaratan TransCon Growth Hormone Ascendis Pharma A/S Catalent Inc. Cook Group Inc. Versartis Inc....
BioCentury | Sep 27, 2017
Financial News

Follow-on roundup: Ascendis, Catalent

...its TransCon Growth Hormone (ACP-001) to treat pre-pubertal growth hormone deficiency (GHD). On Sept. 22, Versartis Inc....
BioCentury | Sep 22, 2017
Clinical News

Versartis falls on Phase III GHD miss

...In the ITT population, the lower bound of the two-sided 95% CI was -2.3 cm/year. Versartis...
...continue to evaluate the data and provide an update on the program later this year. Versartis...
...to the long-acting recombinant human growth hormone (rhGH) from Amunix Operating Inc. (Mountain View, Calif.). Versartis...
BioCentury | Sep 22, 2017
Financial News

Versartis plummets on Phase III GHD miss

...continue to evaluate the data and provide an update on the program later this year. Versartis...
...its TransCon Growth Hormone (ACP-001) to treat pre-pubertal GHD. Brian Moy ACP-001 Somavaratan TransCon Growth Hormone VRS-317 Amunix Pharmaceuticals Inc. Ascendis Pharma A/S Versartis Inc....
Items per page:
1 - 10 of 92
BioCentury | Aug 21, 2018
Company News

Management tracks: HBP parts ways with Executive Director Chris Ebell

...to 2017. Gene therapy company uniQure hired Robert Gut as CMO. He was CMO at Versartis Inc....
BioCentury | May 29, 2018
Company News

Management tracks: Axovant, Revance

...Bellicum Pharmaceuticals Inc. (NASDAQ:BLCM) hired Shane Ward as general counsel. He was general counsel for Versartis Inc....
BioCentury | Apr 23, 2018
Company News

Management tracks: Probiodrug, Alder

...Biosciences Inc. (Bedford, Mass.) appointed Joshua Brumm as CFO. He was CFO and COO at Versartis Inc....
BioCentury | Oct 13, 2017
Company News

Management tracks: Verastem, OxThera

...NYSE:BMY). Endocrine and metabolic company Versartis Inc. (NASDAQ:VSAR) terminated chief development officer Colin Hislop. He was Versartis'...
BioCentury | Oct 6, 2017
Finance

Bargain shopping

...50% to leave Zai with a market cap of $1.4 billion at the quarter’s close. Versartis Inc....
...and Drug Administration (FDA), Silver Spring, Md. Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX), Laval, Quebec Versartis Inc....
...Ltd. Genocea Biosciences Inc. Gilead Sciences Inc. Intercept Pharmaceuticals Inc. Ionis Pharmaceuticals Inc. Kite Pharma Inc. Marinus Pharmaceuticals Inc. Sanofi Teva Pharmaceutical Industries Ltd. Versartis Inc. Vertex...
BioCentury | Oct 6, 2017
Finance

High as a Kite

...stocks and drug projects,” said Brüning. Annette Grimaldi of BMO Capital Markets agreed, and highlighted Versartis Inc....
...deficiency. The NBI dropped just 0.3% on the day, while the BTK nudged up 0.2%. Versartis...
...Inc. (NASDAQ:RYTM), Boston, Mass. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Versartis Inc....
BioCentury | Sep 29, 2017
Financial News

Ascendis and Catalent price follow-ons

...its TransCon Growth Hormone (ACP-001) to treat pre-pubertal growth hormone deficiency (GHD). On Sept. 22, Versartis Inc....
...Hellerup, Denmark Catalent Inc. (NYSE:CTLT), Somerset, N.J. Elizabeth S. Eaton Somavaratan TransCon Growth Hormone Ascendis Pharma A/S Catalent Inc. Cook Group Inc. Versartis Inc....
BioCentury | Sep 27, 2017
Financial News

Follow-on roundup: Ascendis, Catalent

...its TransCon Growth Hormone (ACP-001) to treat pre-pubertal growth hormone deficiency (GHD). On Sept. 22, Versartis Inc....
BioCentury | Sep 22, 2017
Clinical News

Versartis falls on Phase III GHD miss

...In the ITT population, the lower bound of the two-sided 95% CI was -2.3 cm/year. Versartis...
...continue to evaluate the data and provide an update on the program later this year. Versartis...
...to the long-acting recombinant human growth hormone (rhGH) from Amunix Operating Inc. (Mountain View, Calif.). Versartis...
BioCentury | Sep 22, 2017
Financial News

Versartis plummets on Phase III GHD miss

...continue to evaluate the data and provide an update on the program later this year. Versartis...
...its TransCon Growth Hormone (ACP-001) to treat pre-pubertal GHD. Brian Moy ACP-001 Somavaratan TransCon Growth Hormone VRS-317 Amunix Pharmaceuticals Inc. Ascendis Pharma A/S Versartis Inc....
Items per page:
1 - 10 of 92